OQS
PLRX icon

Occudo Quantitative Strategies’s Pliant Therapeutics PLRX Stock Holding History

Occudo Quantitative Strategies’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,756
Closed -$249K – 1235
2023
Q2 		$249K Buy
+13,756
New +$326K 0.03% 793
2022
Q4 		– Sell
-13,438
Closed -$281K – 1278
2022
Q3 		$281K Sell
13,438
-12,176
-48% -$233K 0.02% 868
2022
Q2 		$205K Buy
25,614
+13,141
+105% +$84.1K 0.02% 905
2022
Q1 		$87K Buy
+12,473
New +$127K 0.01% 1033

Other funds holding PLRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Occudo Quantitative Strategies's PLRX Position: Q3 2023 in Review

Occudo Quantitative Strategies sold out of Pliant Therapeutics (PLRX) in Q3 2023, closing a stake of 13,756 shares — an estimated $249K sold.

Occudo Quantitative Strategies first reported a position in PLRX in Q1 2022 and held it in 4 quarters. The position peaked at $281K in Q3 2022. 136 funds tracked by Wall St. Rank hold PLRX as of Q3 2023.

  • Occudo Quantitative Strategies reported no remaining Pliant Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 13,756 Pliant Therapeutics shares in Q3 2023, an estimated $249K.
  • Occudo Quantitative Strategies first reported a position in Pliant Therapeutics in Q1 2022 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Pliant Therapeutics position peaked at $281K in Q3 2022.
  • 136 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.